4-methyl-valeric acid isobutyl ester | 25415-70-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 4-methyl-valeric acid isobutyl ester
• 英文别名: 4-Methyl-valeriansaeure-isobutylester；4-methyl-pentanoic acid, 2-methylpropyl ester；Pentanoic acid, 4-methyl, 2-methylpropyl ester；2-methylpropyl 4-methylpentanoate
• CAS: 25415-70-7
• 化学式: C₁₀H₂₀O₂
• 分子量: 172.268
• InChiKey: KCLPHAFBBIUUNI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  12
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-methyl-valeric acid isobutyl ester 在 copper chromite 、 异丁醇 作用下， 200.0~225.0 ℃ 、58.84 MPa 条件下， 生成 乙二醇单异丁醚
  参考文献：
  名称：

  Hydrogenation of alkoxy-substituted esters and products

  摘要：

  公开号：

  US02321608A1
• 作为产物：
  描述：

  4-methyl-pent-4-enoic acid methallyl ester 在 镍 作用下， 50.0 ℃ 、9.81 MPa 条件下， 生成 4-methyl-valeric acid isobutyl ester
  参考文献：
  名称：

  Transetherification Reactions. Preparation and Rearrangement of β-Alloxyacrylates¹

  摘要：

  DOI：

  10.1021/ja01158a040

文献信息

• Pyrrolopyridazinone Compound
  申请人：Hagihara Masahiko

  公开号：US20090036453A1

  公开（公告）日：2009-02-05

  The present invention discloses a pyrrolopyridazinone compound represented by the formula (1): wherein R 1 represents C 1 -C 2 alkyl group or halogeno C 1 -C 2 alkyl group, R 2 repersents C 3 -C 5 cycloalkyl group, (C 3 -C 5 cycloalkyl)C 1 -C 2 alkyl group or C 1 -C 3 alkyl group, R 3 represents hydrogen atom, or methylene group or cis-vinylene group for forming substituted oxygen-containing hetero ring in combination with group —O—R 2 , R 4 represents hydrogen atom, halogen atom, C 1 -C 8 alkyl group, C 2 -C 6 alkenyl group, C 2 -C 6 alkynyl group, hydroxy C 3 -C 6 alkenyl group, hydroxy C 3 -C 6 alkynyl group, C 1 -C 6 alkyl group substituted by substituent(s) selected from Substituent group (a), C 3 -C 6 cycloalkyl group which may be substituted by substituent(s) selected from Substituent group (b), “C 1 -C 3 alkyl group which is substituted by C 3 -C 6 cycloalkyl group which may be substituted by substituent(s) selected from Substituent group (b), and which may be substituted by a hydroxy group”, an aromatic ring group or heteroaromatic ring group each of which may be substituted by a substituent(s) selected from Substituent group (c) or “C 1 -C 2 alkyl group which is substituted by aromatic ring group or heteroaromatic ring group each of which may be substituted by group(s) selected from Substituent group (c), and which may be substituted by a hydroxy group”, Substituent group (a) represents a halogen atom, hydroxy group, cyano group, carboxy group, C 1 -C 5 alkoxy group, halogeno C 1 -C 4 alkoxy group, C 3 -C 6 cycloalkoxy group, (C 3 -C 6 cycloalkyl)C 1 -C 2 alkoxy group, C 1 -C 4 alkoxycarbonyl group, C 2 -C 4 alkanoyl group, C 2 -C 4 alkanoyloxy group or C 1 -C 4 alkyl-substituted amino group, Substituent group (b) represents a hydroxy group or a halogen atom, Substituent group (c) represents a halogen atom, a hydroxy group, a cyano group, a nitro group, a carboxy group, C 1 -C 5 alkoxy group, C 1 -C 4 alkoxycarbonyl group, C 2 -C 4 alkanoyloxy group, C 1 -C 4 alkyl-substituted amino group or a C 1 -C 4 alkyl group which may be substituted by a substituent(s) selected from the group consisting of (a halogen atom, a hydroxy group and a carboxy group), or a pharmaceutically acceptable salt thereof.

  本发明公开了一种由式（1）表示的吡咯吡啶二酮化合物：其中，R1代表C1-C2烷基或卤代C1-C2烷基，R2代表C3-C5环烷基、（C3-C5环烷基）C1-C2烷基或C1-C3烷基，R3代表氢原子，或与基团-O-R2结合形成取代含氧杂环的亚甲基或顺式乙烯基，R4代表氢原子、卤素原子、C1-C8烷基、C2-C6烯基、C2-C6炔基、羟基C3-C6烯基、羟基C3-C6炔基、由从取代基团（a）中选择的取代基团取代的C1-C6烷基，可由从取代基团（b）中选择的取代基团取代的C3-C6环烷基，可由从取代基团（b）中选择的取代基团取代的C1-C3烷基，且可由羟基取代，芳香环基或杂芳香环基，每个都可由从取代基团（c）中选择的取代基团取代或由取代基团（c）选择的基团取代的C1-C2烷基，且可由羟基取代，取代基团（a）表示卤素原子、羟基、氰基、羧基、C1-C5烷氧基、卤代C1-C4烷氧基、C3-C6环烷氧基、（C3-C6环烷基）C1-C2烷氧基、C1-C4烷氧羰基、C2-C4酰基、C2-C4酰氧基或C1-C4烷基取代的氨基基团，取代基团（b）表示羟基或卤素原子，取代基团（c）表示卤素原子、羟基、氰基、硝基、羧基、C1-C5烷氧基、C1-C4烷氧羰基、C2-C4酰氧基、C1-C4烷基取代的氨基基团或可由从由卤素原子、羟基和羧基组成的基团中选择的取代基团取代的C1-C4烷基，或其药学上可接受的盐。
• PRODRUGS OF PEPTIDE EPOXY KETONE PROTEASE INHIBITORS
  申请人：Onyx Therapeutics, Inc.

  公开号：US20160263234A1

  公开（公告）日：2016-09-15

  This disclosure features compounds that are useful as pro-drugs of epoxy ketone protease inhibitors.

  本公开涉及一类作为环氧酮蛋白酶抑制剂的前药有用的化合物。
• Benzimidazole derivatives
  申请人：Enanta Pharmaceuticals, Inc.

  公开号：US10017499B2

  公开（公告）日：2018-07-10

  The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

  本发明公开了式（I）化合物或其药学上可接受的盐、酯或原药： 它们能抑制含 RNA 的病毒，特别是丙型肝炎病毒（HCV）。因此，本发明的化合物可干扰丙型肝炎病毒的生命周期，也可用作抗病毒药物。本发明进一步涉及包含上述化合物的药物组合物，用于给丙型肝炎病毒感染者用药。本发明还涉及通过施用包含本发明化合物的药物组合物治疗受试者感染 HCV 的方法。
• Method, apparatus and chemical products for treating petroleum equipment
  申请人：Ferrara Marcello

  公开号：US10106752B2

  公开（公告）日：2018-10-23

  The present invention provides a method, an apparatus and chemical products for treating petroleum equipment wherein a fluid is flowing, preferably of the hydrocarbon type, and wherein treating is performed by establishing a closed or semi-closed flow circulation loop, during the normal production operations of the equipment. The treatment can refer to the cleaning of equipment, to yield improvement as compared to normal run conditions and/or to a reduction of coke formation and/or to coke removal on catalysts.

  本发明提供了一种处理石油设备的方法、装置和化学产品，该设备中流动着流体，最好是烃类流体，在设备的正常生产操作过程中，通过建立一个封闭或半封闭的流动循环回路进行处理。处理可以指设备的清洁、与正常运行条件相比产量的提高和/或减少焦炭的形成和/或去除催化剂上的焦炭。
• Cosmetic composition for nails, free of phthalates, camphor and aromatic solvent
  申请人：——

  公开号：US20030152535A1

  公开（公告）日：2003-08-14

  The cosmetic composition for nails without phtalate, without camphor or aromatic solvent comprises: a principal cellulosic filmogenic polymer, preferably nitrocellulose, a diester of benzoic acid with a diol, as a plasticizer, and at least one additive resin. This composition can be used as a colored nail polish or for providing an adherent layer or a clear finish layer.

  不含邻苯二甲酸盐、樟脑或芳香族溶剂的指甲化妆品组合物包括 一种主要的纤维素成膜聚合物，最好是硝化纤维、 苯甲酸与二元醇的二酯，作为增塑剂、 以及至少一种添加剂树脂。 这种组合物可用作彩色指甲油，也可用于提供附着层或透明饰面层。